Alvotech named Sarah Tanksley as chief quality officer Tuesday afternoon.
Tanksley will start her new role on Friday, taking over for Reem Malki, who left due to personal reasons.
Tanksley joins the global biotech with more than 20 years of experience at the National Institutes of Health, the Food and Drug Administration and as an industry consultant.
“Her familiarity with our operation facilitates a smooth transition and we are excited to benefit further from her experience in regulatory compliance and GMP,” Alvotech CEO Mark Levick said in a statement. “Sarah brings strong capabilities to the role of Chief Quality Officer, having excelled in regulatory agency roles as well as a respected industry practitioner. I also want to thank Reem for her vital contribution to the Alvotech team, as we built a world-class biosimilars development and manufacturing platform and achieved successful market launches of our first biosimilar in both Europe and Canada.”
